Search Results
Advanced Hodgkin lymphoma: AHL2011 data update from EHA 2018
Martin Hutchings, EHA 2018 – ECHELON-1 trial and chemotherapy regimens in Hodgkin’s lymphoma
Martin Hutchings | EHA 2018 | Key outcomes of the ECHELON-1 sub-analysis
Astrid Pavlovsky | EHA 2018 | Key highlights from EHA on Hodgkin lymphoma
Hodgkin Lymphoma: ECHELON-1 Update from ASCO 2022
ABVD vs. escBEACOPP in HL: a 10-year study
Debate: Best upfront approach for Advanced Stage Hodgkin Lymphoma? - A (brentuximab vedotin) VD
Clinical Data for Axi-Cel in Lymphoma
What does the future hold for advanced stage Hodgkin's Lymphoma?
Follicular lymphoma: is RELEVANCE relevant?
EHA 2018 Highlights in Myeloma
Brentuximab vedotin plus ESHAP: complete remission in R/R Hodgkin lymphoma
